Ectopic spleen (ES) is a rare condition. It is difficult to diagnose with conventional imaging modalities. In this case series, we presented the imaging features of three misdiagnosed ES cases in our hospital and previously reported cases to compare the consistency of enhancement patterns among different imaging modalities with varied phases. Finally, 22 cases were reviewed. We determined that variable arterial phase enhancement and persistent enhancement throughout the portal and delayed phases are present in contrast-enhanced ultrasound (CEUS) imaging of the ES and found the arterial phase of CEUS had the highest consistency compared with computerized tomography (CT) and magnetic resonance imaging (MRI).
Antiviral treatment reduces, but does not eliminate, the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Predicting HCC risk in this population remains challenging. This study aimed to use dynamic changes in liver stiffness measurement (LSM) obtained using two-dimensional (2D) shear-wave elastography (SWE) to predict HCC in patients with non-cirrhotic and cirrhotic CHB who had well-controlled viremia. We retrospectively enrolled 303 patients with CHB (45 patients with cirrhosis) who had well-controlled viremia (hepatitis B virus DNA < 100 IU/mL for ≥ 6 months) during antiviral treatment. Patients were followed up every 3–6 months and had two to twelve reliable LSMs using 2D SWE. Clinical and laboratory variables, single LSM, change between two LSMs, and dynamic LSM changes were analyzed using least absolute shrinkage and selection operator and multivariable Cox regression analysis to identify risk factors for HCC. Dynamic LSM changes were classified into sustained low LSM (all LSMs ≤ 8.1 kPa), unstable LSM (LSM ≤ 8.1 kPa at least once and > 8.1 kPa at least once), and sustained high LSM (all LSMs > 8.1 kPa). Among the 303 patients, 27 developed HCC. In the multivariable analysis, sustained high LSM in dynamic LSM changes (HR = 11.624, 95% CI: 4.241–31.861; P < 0.001; compared with sustained low LSM) and older age (HR = 1.046, 95% CI: 1.009–1.084; P = 0.013) independently predicted HCC. A novel model combining age and dynamic LSM changes achieved a C-index of 0.845 for internal validation, demonstrating reliable agreement between the predicted and observed probabilities of HCC development. The novel model showed better performance in non-cirrhotic patients with a C-index of 0.860, whereas the C-index was only 0.634 in cirrhotic patients. Dynamic LSM changes can predict HCC in patients with CHB who have well-controlled viremia, especially in non-cirrhotic patients.
24 February 2024 in Arab Journal of Gastroenterology
Acute-on-chronic liver failure (ACLF) is associated with very high mortality. Accurate prediction of prognosis is critical in navigating optimal treatment decisions to improve patient survival. This study was aimed to develop a new nomogram integrating two-dimensional shear wave elastography (2D-SWE) values with other independent prognostic factors to improve the precision of predicting ACLF patient outcomes.
Acute-on-chronic liver failure (ACLF) is associated with a considerably high mortality, and accurate prognosis prediction is critical to navigate intervention decisions and improve clinical outcomes. The objective of this study was to establish a better prognostic model for ACLF based on multiparameter ultrasound in combination with clinical features. A total of 149 patients with ACLF were prospectively enrolled and underwent conventional ultrasound, 2-D shear wave elastography (SWE), attenuation imaging, color Doppler sonography, superb microvascular imaging and contrast-enhanced ultrasound (CEUS). Univariate and multivariate analyses were performed to identify independent ultrasound signatures for the prognosis of ACLF, which, when integrated with clinical characteristics, were used to establish a prognostic model. Hepatic perfusion features of CEUS differed significantly between the poor and good prognosis groups, among which the time interval (TI) between peak portal vein (PV) velocity and liver parenchyma (LP) enhancement, TI(PV, LP), was independently associated with the prognosis of ACLF. A prediction model comprising TI(PV, LP) and the international normalized ratio was established, and the area under the curve (AUC) was 0.851, which is greater than those of the Model for End-stage Liver Disease (0.785), fall time of LP model (0.754), 2-D SWE nomogram (0.708) and TI(PV, LP) (0.352). Furthermore, the performance of the model was verified in an independent validation cohort (AUC = 0.920). The newly developed model performs better than existing tested models; thus, it has potential as a better non-invasive model for predicting the prognosis of patients with ACLF. A future multicenter, large-sample study is required to validate the performance of this model.
Intraoperative brain shift degrades the accuracy of preoperative‑MRI‑based neuronavigation, whereas intraoperative MRI (iMRI) incurs substantial costs. This study investigated a deformation‑field framework based on 3D intraoperative ultrasound (3D-iUS) and optical navigation to warp preoperative MRI into geometrically updated virtual MRI (vMRI) for the correction of brain‑shift‑induced spatial displacement. An optical-ultrasound navigation platform unified 3D iUS and preoperative MRI coordinates. In vitro brain shift phantoms and ex vivo cadaveric specimens simulated bidirectional tumor growth-resection deformation. A B-spline free-form deformation algorithm computed tissue displacement fields from 3D iUS to generate vMRI. Target registration error (TRE) between vMRI and iMRI was calculated using implanted markers and anatomical landmarks. Algorithm performance was assessed by accuracy, real-time capability, and robustness. After deformation correction, mean TRE was 2.94 mm in vitro and 2.28 mm ex vivo, both within the clinically acceptable range (2–3 mm). Image overlay confirmed good alignment of key structures. The algorithm ran stably with a mean core computation time of approximately 2.5 min, demonstrating encouraging computational speed for the deformation-solving step, with further pipeline optimization needed to support practical intraoperative application. The “3D iUS + optical navigation + deformation field” pipeline is feasible in vitro and ex vivo, achieving registration accuracy comparable to iMRI within the clinically acceptable range, though the improvement over rigid baseline did not reach statistical significance. These findings provide a methodological foundation for future in vivo validation and iMRI-free dynamic image-guided navigation.